SG Americas Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.2M Buy
87,840
+77,209
+726% +$43.3M 0.03% 368
2026
Q1
$5.97M Sell
10,631
-32,794
-76% -$21M 0.01% 984
2025
Q4
$29.4M Sell
43,425
-1,608
-4% -$1.1M 0.04% 374
2025
Q3
$28.8M Sell
45,033
-7,247
-14% -$4.4M 0.1% 135
2025
Q2
$28M Sell
52,280
-86,215
-62% -$41.2M 0.12% 127
2025
Q1
$58.2M Buy
138,495
+98,413
+246% +$42.7M 0.19% 68
2024
Q4
$16.6M Buy
40,082
+14,659
+58% +$6.43M 0.07% 156
2024
Q3
$12.8M Sell
25,423
-83,840
-77% -$40.7M 0.05% 235
2024
Q2
$53.2M Buy
109,263
+87,843
+410% +$44.1M 0.31% 58
2024
Q1
$11.6M Buy
21,420
+2,196
+11% +$1.2M 0.06% 328
2023
Q4
$10.7M Sell
19,224
-4,947
-20% -$2.32M 0.1% 196
2023
Q3
$10.6M Buy
24,171
+6,625
+38% +$3.3M 0.12% 159
2023
Q2
$8.81M Buy
17,546
+11,982
+215% +$5.74M 0.07% 202
2023
Q1
$2.78M Sell
5,564
-10,094
-64% -$4.83M 0.03% 503
2022
Q4
$6.39M Buy
15,658
+8,623
+123% +$3.35M 0.08% 206
2022
Q3
$2.29M Sell
7,035
-8,234
-54% -$3.02M 0.03% 527
2022
Q2
$5.36M Buy
15,269
+3,267
+27% +$1.33M 0.06% 283
2022
Q1
$6.57M Buy
12,002
+5,942
+98% +$3.13M 0.05% 320
2021
Q4
$3.99M Buy
6,060
+906
+18% +$569K 0.02% 603
2021
Q3
$3.21M Sell
5,154
-20,256
-80% -$13.6M 0.02% 871
2021
Q2
$16M Buy
25,410
+12,715
+100% +$7.02M 0.07% 227
2021
Q1
$6.21M Sell
12,695
-1,293
-9% -$648K 0.03% 434
2020
Q4
$6.99M Buy
13,988
+9,861
+239% +$4.41M 0.04% 359
2020
Q3
$1.62M Sell
4,127
-18,299
-82% -$6.77M 0.01% 880
2020
Q2
$7.4M Sell
22,426
-582
-3% -$169K 0.06% 236
2020
Q1
$5.57M Sell
23,008
-27,485
-54% -$7.17M 0.05% 342
2019
Q4
$13.2M Buy
50,493
+42,233
+511% +$11.1M 0.12% 140
2019
Q3
$2.25M Buy
8,260
+7,299
+760% +$2.03M 0.02% 884
2019
Q2
$265K Buy
961
+22
+2% +$5.42K ﹤0.01% 2257
2019
Q1
$210K Sell
939
-3,272
-78% -$675K ﹤0.01% 2528
2018
Q4
$783K Sell
4,211
-34,483
-89% -$7.07M 0.01% 1532
2018
Q3
$9.66M Buy
38,694
+17,538
+83% +$4.26M 0.07% 280
2018
Q2
$4.61M Buy
21,156
+10,296
+95% +$2.12M 0.04% 469
2018
Q1
$2.08M Buy
10,860
+1,700
+19% +$314K 0.02% 858
2017
Q4
$1.43M Sell
9,160
-10,316
-53% -$1.62M 0.01% 1107
2017
Q3
$3.03M Buy
19,476
+18,411
+1,729% +$2.91M 0.03% 549
2017
Q2
$172K Sell
1,065
-24,741
-96% -$4.02M ﹤0.01% 2545
2017
Q1
$3.99M Buy
25,806
+13,566
+111% +$1.87M 0.04% 490
2016
Q4
$1.44M Buy
12,240
+4,389
+56% +$501K 0.01% 1101
2016
Q3
$885K Sell
7,851
-55,804
-88% -$5.88M 0.01% 1273
2016
Q2
$5.91M Buy
63,655
+21,200
+50% +$1.82M 0.04% 351
2016
Q1
$3.33M Buy
42,455
+2,767
+7% +$199K 0.02% 567
2015
Q4
$2.89M Buy
39,688
+30,332
+324% +$2.16M 0.02% 548
2015
Q3
$695K Sell
9,356
-17,516
-65% -$1.25M ﹤0.01% 969
2015
Q2
$1.72M Buy
26,872
+5,398
+25% +$374K 0.01% 784
2015
Q1
$1.66M Sell
21,474
-4,862
-18% -$378K 0.01% 900
2014
Q4
$1.95M Buy
26,336
+9,416
+56% +$660K 0.01% 967
2014
Q3
$997K Sell
16,920
-82,622
-83% -$5.22M 0.01% 1159
2014
Q2
$6.65M Buy
99,542
+90,004
+944% +$5.72M 0.04% 478
2014
Q1
$579K Sell
9,538
-7,806
-45% -$465K ﹤0.01% 1392
2013
Q4
$922K Sell
17,344
-30,232
-64% -$1.59M ﹤0.01% 1232
2013
Q3
$2.37M Buy
47,576
+38,758
+440% +$1.86M 0.01% 875
2013
Q2
$396K Buy
+8,818
New +$385K ﹤0.01% 1363

Other funds holding IDXX

SG Americas Securities's IDXX Position: Q2 2026 in Review

SG Americas Securities increased its Idexx Laboratories (IDXX) stake by 726% in Q2 2026, buying an estimated $43.3M and bringing the position to 87,840 shares worth $46.2M. The position accounts for 0.03% of the portfolio, ranked #368.

SG Americas Securities first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $58.2M in Q1 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • SG Americas Securities held 87,840 shares of Idexx Laboratories worth $46.2M as of Q2 2026.
  • SG Americas Securities bought 77,209 Idexx Laboratories shares in Q2 2026, an estimated $43.3M.
  • Idexx Laboratories made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #368 holding.
  • SG Americas Securities first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • SG Americas Securities's Idexx Laboratories position peaked at $58.2M in Q1 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.